Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 0 | 0 | 0 | 10 | 0 |
| Gross Profit | N/A | 0 | 10 | 10 | 0 |
| Operating Expenses | 18,509 | 31,150 | 18,430 | 22,280 | 17,910 |
| Operating Income | -18,509 | -31,150 | -18,430 | -22,270 | -17,910 |
| Interest Expense | 0 | 0 | 0 | 70 | 0 |
| Other Income | -5,261 | 2,210 | 0 | 1,960 | 2,460 |
| Pre-tax Income | -23,770 | -28,940 | -18,430 | -20,380 | -15,450 |
| Net Income Continuous | -23,770 | -35,111 | -24,736 | -20,389 | -15,457 |
| Net Income | $-23,770 | $-28,940 | $-24,736 | $-20,380 | $-15,450 |
| EPS Basic Total Ops | -71.60 | -158.46 | -168.07 | -175.27 | -134.45 |
| EPS Basic Continuous Ops | -71.60 | -157.80 | -193.70 | -175.31 | -134.29 |
| EPS Diluted Total Ops | -71.60 | -158.46 | -168.07 | -175.27 | -134.45 |
| EPS Diluted Continuous Ops | -71.60 | -157.80 | -193.70 | -175.31 | -134.29 |
| EBITDA(a) | $-18,315 | $-30,930 | $-18,200 | $-22,060 | $-17,730 |